Saturday’s Shergar Cup Sprint at Ascot shapes up as one of the most compelling races on the card, with the six-furlong contest attracting a strong and progressive field. Thunder Call enters the
Utility stocks have attracted growing investor interest in 2026 as persistent inflation and ongoing tariff pressures reshape the broader investment landscape. The sector is traditionally viewed as a defensive play, offering stable
More
Apple (AAPL) has filed a lawsuit against OpenAI and two of its former employees, accusing them of stealing confidential information about its unreleased technologies and products. The iPhone maker filed the suit
More
Attorneys at McDermott Will & Schulte LLP have compiled the latest 340B litigation updates covering the week of June 30 through July 6, 2026. The weekly roundup draws on a review of
More
Sullivan & Cromwell is facing significant internal tensions after reports emerged that the firm quietly crossed a line partners were explicitly promised would not be crossed. The Wall Street Journal has confirmed
More
Bitcoin and cryptocurrency-linked equities are drawing increased investor attention as markets brace for the release of the latest US Consumer Price Index report. Inflation data has long been a key driver of
More
Playtech (PTEC) shares climbed sharply as the gambling technology firm issued an earnings upgrade, drawing significant attention from investors across the FTSE 250 index. The upgrade signalled stronger than expected trading performance
More
Proposed FAR Overhaul Slashes Contractor Deadlines For Termination Settlement Submissions To 90 Days
The Federal Acquisition Regulation faces its most significant overhaul in years, with new proposed rules that would dramatically compress deadlines for government contractors handling terminated contracts. The Revolutionary FAR Overhaul, known as
More
The Supreme Court’s recent decision on birthright citizenship has drawn fierce public opposition from President Donald Trump, who is now demanding an immediate rehearing. Trump took to social media to denounce the
More
AstraZeneca PLC (LSE: AZN, NASDAQ: AZN) has taken a significant reputational hit following the failure of its Wainua drug trial, according to analysts at Jefferies. The broker argues the damage is less
More
For years, Americans absorbed “funflation” as a problem confined to concerts and stadiums, but that boundary no longer holds. Rising prices from companies including Amazon, Apple, Netflix, Microsoft, and Spotify have extended
More